{"title":"在实验条件下，抗结核药物“瑞法布汀”的毒理学安全性概况","authors":"K. Usov","doi":"10.36629/2686-777x-2022-1-16-209-214","DOIUrl":null,"url":null,"abstract":"The article is devoted to an experimental study to determine the toxicological safety profile of the anti-tuberculosis drug «Rifabutin» with prolonged exposure to experimental animals","PeriodicalId":280015,"journal":{"name":"Bulletin of the Angarsk State Technical University","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TOXICOLOGICAL SAFETY PROFILE ANTI-TUBERCULOSIS DRUG «RIFABUTIN» WITH PROLONGED ADMINISTRATION UNDER EXPERIMENTAL CONDITIONS\",\"authors\":\"K. Usov\",\"doi\":\"10.36629/2686-777x-2022-1-16-209-214\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article is devoted to an experimental study to determine the toxicological safety profile of the anti-tuberculosis drug «Rifabutin» with prolonged exposure to experimental animals\",\"PeriodicalId\":280015,\"journal\":{\"name\":\"Bulletin of the Angarsk State Technical University\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of the Angarsk State Technical University\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36629/2686-777x-2022-1-16-209-214\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the Angarsk State Technical University","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36629/2686-777x-2022-1-16-209-214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
TOXICOLOGICAL SAFETY PROFILE ANTI-TUBERCULOSIS DRUG «RIFABUTIN» WITH PROLONGED ADMINISTRATION UNDER EXPERIMENTAL CONDITIONS
The article is devoted to an experimental study to determine the toxicological safety profile of the anti-tuberculosis drug «Rifabutin» with prolonged exposure to experimental animals
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
